A Tame CPI Report Unleashed a Broad Rally — But Two Micro-Caps Stole the Show
Wednesday’s session had a clear macro trigger: a cooler-than-feared July CPI reading eased near-term Fed rate-hike anxiety and sent AI infrastructure names surging, with CoreWeave and Nebius both posting earnings-driven gains north of 20%. But the day’s single biggest percentage movers weren’t AI names at all — they were two microscopic-float turnaround stories that ripped 100%+ on takeover chatter and a historic reverse-split squeeze. Here are today’s top stock gainers, ranked by percentage move.
1. OFA Group (OFAL) — Up as Much as 320.63%, Settling Near +183%
Fundamental Data:
| Metric | Value |
|---|---|
| Today’s Move | +172% to +320.63% (intraday high), settled near +183.24% |
| Late-July Price | $0.10 – $0.12 |
| July 31 Close | $1.03 |
| Today’s Intraday High | Above $2.89 |
| Catalyst | 1-for-10 reverse split + earnings beat + optimistic guidance |
| Cash on Hand | ~$0.03 million |
| Current Liabilities | ~$0.22 million |
What Happened: OFA Group staged one of the most explosive low-float squeezes of the year, rocketing from sub-$0.12 in late July to intraday highs above $2.89 today — a move traders are calling a “textbook momentum playground.” The catalyst combines a recent 1-for-10 reverse stock split with strong earnings and optimistic forward guidance, though the company’s balance sheet remains extremely thin, with roughly $30,000 in cash against over $220,000 in current liabilities.
Why It Matters / What to Watch Tomorrow: With negative equity and high leverage, OFAL trades almost entirely on technicals and crowd psychology rather than fundamentals. Traders are watching whether the $1.30-$1.60 zone holds as new support after today’s parabolic move, or whether the stock gives back its gains just as violently as it built them.
2. Rocky Mountain Chocolate Factory (RMCF) — A Sale Process Sparks a 129-163% Surge
Fundamental Data:
| Metric | Value |
|---|---|
| Today’s Move | +129% to +163.2% |
| Pre-Move Price | Below $0.70-$1.00 |
| Intraday High | Near $2.00 |
| Trailing Revenue | ~$27.5 million |
| Gross Margin | ~58% |
| Cash Position | ~$609,000 |
What Happened: Rocky Mountain Chocolate Factory’s board disclosed it is exploring strategic alternatives that could include a sale, merger, or going-private transaction, sending shares nearly doubling intraday after weeks of steady downside. Despite the surge, the underlying business remains in turnaround territory with roughly $1.17 million in quarterly net losses and tight liquidity.
Why It Matters / What to Watch Tomorrow: A confirmed strategic review with real acquisition premium potential gives RMCF genuine catalyst-driven upside, but with only about $609,000 in cash, the company’s negotiating position could be weaker than the stock’s enthusiasm suggests. Watch for any formal bidder names or a specific transaction timeline in coming sessions.
3. CoreWeave, Inc. (CRWV) — A Raised Capex Forecast Fuels a 21.6% Rally
Fundamental Data:
| Metric | Value |
|---|---|
| Today’s Move | +21.60% to $109.83 |
| Premarket Move | +18% to ~$107 |
| New 2026 Capex Guidance | $35-39 billion (raised from $31-35 billion) |
| Backlog | $99.4 billion+ (including Meta’s $21B commitment) |
What Happened: CoreWeave posted upbeat Q2 results and raised its 2026 capital spending forecast to $35-39 billion from a prior $31-35 billion range, alongside raised guidance for both 2026 revenue and adjusted operating profit — a decisive reversal from the stock’s volatile trading pattern over recent weeks.
Why It Matters / What to Watch Tomorrow: The raised capex guidance signals management’s confidence in continued hyperscaler demand converting into locked-in infrastructure spending. Watch whether the stock can hold above $107-110 through the rest of the week, or whether today’s move proves to be another short-lived relief rally in an otherwise volatile 2026 for the stock.
4. Bloom Energy Corp (BE) — JPMorgan’s Upgrade Drives a 15.3% Pop
Fundamental Data:
| Metric | Value |
|---|---|
| Today’s Move | +15.3% |
| Catalyst | JPMorgan price target raise |
What Happened: JPMorgan raised its price target on Bloom Energy, reinforcing the fuel cell maker’s positioning at the center of the AI data center power demand theme that’s driven the stock’s volatile but generally upward 2026 trajectory.
Why It Matters / What to Watch Tomorrow: A major analyst upgrade tied specifically to AI-energy infrastructure demand adds validation to Bloom’s core investment thesis. Watch for follow-through buying and whether other analysts adjust targets in response over the coming sessions.
5. Super Micro Computer (SMCI) — Guidance Beat Sends Shares Up 14.4%
Fundamental Data:
| Metric | Value |
|---|---|
| Today’s Move | +14.37% to $36.14 |
| Premarket Move | +9% |
| Order Backlog Addition | $60+ billion in fresh purchase commitments disclosed |
What Happened: Super Micro Computer’s results and sharply higher forward guidance drove a strong session, with the company having previously disclosed over $60 billion in fresh purchase commitments during the reporting period — pushing its order backlog to unprecedented levels heading into this report.
Why It Matters / What to Watch Tomorrow: With such a substantial backlog addition, investors will be watching gross margin trends specifically, since backlog growth alone doesn’t guarantee profitable conversion. Watch upcoming commentary on 800G and 1.6T networking component demand as a leading indicator of sustained momentum.
6. Boxlight Corporation (BOXL) — A Financial Runway Play Gains 60%
Fundamental Data:
| Metric | Value |
|---|---|
| Today’s Move | +60% |
| Catalyst | Financing/runway extension effort |
What Happened: Boxlight shares surged as the education technology company works to extend its financial runway, part of a broader session where multiple small-cap turnaround and financing stories drove outsized single-day moves.
Why It Matters / What to Watch Tomorrow: A 60% single-day move on a financing-related catalyst suggests speculative positioning ahead of confirmed details — watch for the actual terms of any financing arrangement, which will determine whether today’s optimism is warranted or overdone.
7. Nokia Oyj (NOK) — European Tech Strength Adds 9.7%
Fundamental Data:
| Metric | Value |
|---|---|
| Today’s Move | +9.69% to $10.36 |
| Dollar Gain | +$0.91 |
What Happened: Nokia shares climbed alongside broader European technology and telecom sector strength today, part of a session where continental earnings beats — including ABN AMRO’s 4.9% surge on a Q2 profit beat — provided pockets of outperformance.
Why It Matters / What to Watch Tomorrow: Nokia’s move reflects broader sector rotation rather than a company-specific catalyst; watch for confirmation of sustained telecom equipment demand trends in upcoming earnings from peers.
8. Lumentum Holdings (LITE) — Optical Component Strength Continues, +7%
Fundamental Data:
| Metric | Value |
|---|---|
| Today’s Move | +7% |
| YTD Performance (entering report) | +94% to +141% |
| Prior Quarter Revenue | Record $808 million |
What Happened: Lumentum shares rose on better-than-expected results, extending the optical components maker’s strong 2026 performance as AI datacom infrastructure demand continues supporting the entire optical networking supply chain.
Why It Matters / What to Watch Tomorrow: With the stock already up dramatically year-to-date, today’s gain reinforces that AI infrastructure demand for optical components remains robust. Watch for details on the previously flagged multi-hundred-million co-packaged optics order expected in H1 2027.
9. Definium Therapeutics — Phase 3 Data Sparks a 20% Premarket Jump
Fundamental Data:
| Metric | Value |
|---|---|
| Premarket Move | +20% |
| Catalyst | Positive Phase 3 trial results |
What Happened: Definium Therapeutics jumped premarket on positive Phase 3 trial results, a meaningful de-risking event for the clinical-stage biotech’s pipeline.
Why It Matters / What to Watch Tomorrow: Positive Phase 3 data is one of the most significant catalysts available to a clinical-stage biotech, substantially reducing regulatory approval risk. Watch for the full data set details and any subsequent analyst coverage initiations following today’s move.
10. NeOnc Technologies Holdings (NTHI) — A Clinical Beat Drives Gains
Fundamental Data:
| Metric | Value |
|---|---|
| Catalyst | NEO100 beat six-month progression-free-survival benchmark by ~2.5x |
What Happened: NeOnc Technologies delivered a major clinical catalyst after its NEO100 treatment beat the six-month progression-free-survival benchmark by nearly 2.5 times in trial data released today.
Why It Matters / What to Watch Tomorrow: A 2.5x outperformance versus a pre-specified clinical benchmark is an unusually strong efficacy signal. Watch for how this data translates into updated regulatory pathway guidance and whether larger institutional investors begin building positions on the strength of this readout.
Quick-Reference Table: Today’s Top 10 Gainers
| Rank | Ticker | Company | Today’s Move | Catalyst |
|---|---|---|---|---|
| 1 | OFAL | OFA Group | +183% (up to +320% intraday) | Reverse split + earnings |
| 2 | RMCF | Rocky Mountain Chocolate | +129% to +163% | Strategic alternatives/sale review |
| 3 | CRWV | CoreWeave | +21.60% | Raised capex guidance, Q2 beat |
| 4 | BE | Bloom Energy | +15.3% | JPMorgan price target raise |
| 5 | SMCI | Super Micro Computer | +14.37% | Earnings beat, higher guidance |
| 6 | BOXL | Boxlight Corp | +60% | Financial runway extension |
| 7 | NOK | Nokia Oyj | +9.69% | Sector-wide European tech strength |
| 8 | LITE | Lumentum Holdings | +7% | Beat, AI datacom demand |
| 9 | — | Definium Therapeutics | +20% (premarket) | Positive Phase 3 data |
| 10 | NTHI | NeOnc Technologies | Gains on trial data | NEO100 beat PFS benchmark 2.5x |
Sector Sentiment Snapshot and Forecast
Today’s gainers list splits cleanly into two distinct stories: a tame CPI reading unlocked genuine, fundamentals-backed gains across AI infrastructure names (CoreWeave, Super Micro, Lumentum, Bloom Energy), while a handful of ultra-low-float micro-caps (OFA Group, Rocky Mountain Chocolate, Boxlight) posted even larger percentage moves on reverse-split mechanics, sale speculation, and financing headlines rather than operating fundamentals. The biotech gainers (Definium, NeOnc) reflect the market’s continued appetite for binary clinical catalysts regardless of broader macro sentiment. With CPI-driven relief supporting the AI infrastructure trade broadly, expect continued momentum in that group tomorrow, while the micro-cap squeeze names remain far riskier bets likely to see sharp reversals as quickly as they rallied.
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss, and micro-cap, low-float securities carry substantially elevated volatility and liquidity risk. Prices and figures cited reflect data available as of August 12, 2026 and are sourced from publicly available market data. Always complete independent due diligence prior to executing equity trades.
About The Author
